Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Plasma total cholesterol level as a risk factor for Alzheimer disease: the Framingham Study.

Tan ZS, Seshadri S, Beiser A, Wilson PW, Kiel DP, Tocco M, D'Agostino RB, Wolf PA.

Arch Intern Med. 2003 May 12;163(9):1053-7.

PMID:
12742802
2.

Biomarkers for insulin resistance and inflammation and the risk for all-cause dementia and alzheimer disease: results from the Framingham Heart Study.

van Himbergen TM, Beiser AS, Ai M, Seshadri S, Otokozawa S, Au R, Thongtang N, Wolf PA, Schaefer EJ.

Arch Neurol. 2012 May;69(5):594-600.

3.

Diabetes mellitus and risk of developing Alzheimer disease: results from the Framingham Study.

Akomolafe A, Beiser A, Meigs JB, Au R, Green RC, Farrer LA, Wolf PA, Seshadri S.

Arch Neurol. 2006 Nov;63(11):1551-5.

PMID:
17101823
4.

Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease.

Notkola IL, Sulkava R, Pekkanen J, Erkinjuntti T, Ehnholm C, Kivinen P, Tuomilehto J, Nissinen A.

Neuroepidemiology. 1998;17(1):14-20.

PMID:
9549720
5.

Cholesterol, APOE genotype, and Alzheimer disease: an epidemiologic study of Nigerian Yoruba.

Hall K, Murrell J, Ogunniyi A, Deeg M, Baiyewu O, Gao S, Gureje O, Dickens J, Evans R, Smith-Gamble V, Unverzagt FW, Shen J, Hendrie H.

Neurology. 2006 Jan 24;66(2):223-7.

6.

Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease.

Kivipelto M, Helkala EL, Laakso MP, Hänninen T, Hallikainen M, Alhainen K, Iivonen S, Mannermaa A, Tuomilehto J, Nissinen A, Soininen H.

Ann Intern Med. 2002 Aug 6;137(3):149-55.

PMID:
12160362
7.

Dementia and Alzheimer disease incidence: a prospective cohort study.

Kukull WA, Higdon R, Bowen JD, McCormick WC, Teri L, Schellenberg GD, van Belle G, Jolley L, Larson EB.

Arch Neurol. 2002 Nov;59(11):1737-46.

PMID:
12433261
8.

Plasma beta amyloid and the risk of Alzheimer disease and dementia in elderly men: a prospective, population-based cohort study.

Sundelöf J, Giedraitis V, Irizarry MC, Sundström J, Ingelsson E, Rönnemaa E, Arnlöv J, Gunnarsson MD, Hyman BT, Basun H, Ingelsson M, Lannfelt L, Kilander L.

Arch Neurol. 2008 Feb;65(2):256-63. doi: 10.1001/archneurol.2007.57.

PMID:
18268197
9.

APOE genotype and cholesterol levels in lewy body dementia and Alzheimer disease: investigating genotype-phenotype effect on disease risk.

Borroni B, Grassi M, Costanzi C, Archetti S, Caimi L, Padovani A.

Am J Geriatr Psychiatry. 2006 Dec;14(12):1022-31.

PMID:
16956959
10.

Low-density lipoprotein cholesterol and the risk of dementia with stroke.

Moroney JT, Tang MX, Berglund L, Small S, Merchant C, Bell K, Stern Y, Mayeux R.

JAMA. 1999 Jul 21;282(3):254-60.

PMID:
10422994
11.

Serum cholesterol and risk of Alzheimer disease: a community-based cohort study.

Li G, Shofer JB, Kukull WA, Peskind ER, Tsuang DW, Breitner JC, McCormick W, Bowen JD, Teri L, Schellenberg GD, Larson EB.

Neurology. 2005 Oct 11;65(7):1045-50.

PMID:
16217057
12.

High total cholesterol levels in late life associated with a reduced risk of dementia.

Mielke MM, Zandi PP, Sjögren M, Gustafson D, Ostling S, Steen B, Skoog I.

Neurology. 2005 May 24;64(10):1689-95.

PMID:
15911792
13.

Serum cystatin C and the risk of Alzheimer disease in elderly men.

Sundelöf J, Arnlöv J, Ingelsson E, Sundström J, Basu S, Zethelius B, Larsson A, Irizarry MC, Giedraitis V, Rönnemaa E, Degerman-Gunnarsson M, Hyman BT, Basun H, Kilander L, Lannfelt L.

Neurology. 2008 Sep 30;71(14):1072-9. doi: 10.1212/01.wnl.0000326894.40353.93.

14.

Contribution of vascular risk factors to the progression in Alzheimer disease.

Helzner EP, Luchsinger JA, Scarmeas N, Cosentino S, Brickman AM, Glymour MM, Stern Y.

Arch Neurol. 2009 Mar;66(3):343-8. doi: 10.1001/archneur.66.3.343.

15.

Changes in apolipoprotein E expression in response to dietary and pharmacological modulation of cholesterol.

Petanceska SS, DeRosa S, Sharma A, Diaz N, Duff K, Tint SG, Refolo LM, Pappolla M.

J Mol Neurosci. 2003;20(3):395-406.

PMID:
14501024
16.

Alcohol intake and risk of dementia.

Luchsinger JA, Tang MX, Siddiqui M, Shea S, Mayeux R.

J Am Geriatr Soc. 2004 Apr;52(4):540-6.

PMID:
15066068
17.

Parental history of Alzheimer disease associated with lower plasma apolipoprotein E levels.

van Vliet P, Westendorp RG, Eikelenboom P, Comijs HC, Frölich M, Bakker E, van der Flier W, van Exel E.

Neurology. 2009 Sep 1;73(9):681-7. doi: 10.1212/WNL.0b013e3181b59c2e.

18.

The 32-year relationship between cholesterol and dementia from midlife to late life.

Mielke MM, Zandi PP, Shao H, Waern M, Östling S, Guo X, Björkelund C, Lissner L, Skoog I, Gustafson DR.

Neurology. 2010 Nov 23;75(21):1888-95. doi: 10.1212/WNL.0b013e3181feb2bf.

19.

Direct, progressive association of cardiovascular risk factors with incident proteinuria: results from the Korea Medical Insurance Corporation (KMIC) study.

Jee SH, Boulware LE, Guallar E, Suh I, Appel LJ, Miller ER 3rd.

Arch Intern Med. 2005 Oct 24;165(19):2299-304.

PMID:
16246998
20.

Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease.

Graff-Radford NR, Crook JE, Lucas J, Boeve BF, Knopman DS, Ivnik RJ, Smith GE, Younkin LH, Petersen RC, Younkin SG.

Arch Neurol. 2007 Mar;64(3):354-62. Erratum in: Arch Neurol. 2007 Sep;64(9):1246.

PMID:
17353377
Items per page

Supplemental Content

Support Center